Qiagen NV is a leading provider of sample-to-knowledge solutions that transform biological materials into actionable molecular insights, serving a diverse range of customers in the life sciences, clinical diagnostics, and pharmaceutical sectors. Headquartered in Venlo, the Netherlands, the company leverages advanced technologies to facilitate genomic and proteomic analysis, enabling researchers and clinicians to make informed decisions based on comprehensive molecular data. With a strong focus on innovation and quality, Qiagen is well-positioned to capitalize on the growing demand for molecular testing and personalized healthcare solutions globally.